FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Enoxaparin Sodium Injection
Status: Discontinuation
»Therapeutic Categories: Hematology

Expand all

Sandoz (New 07/02/2018)

Company Contact Information:
800-525-8747

Presentation Posting Date Related Information
30mg/0.3mL (NDCs 0781-3133-01 and 0781-3133-63) 07/02/2018 Sandoz Inc. has made a business decision to permanently discontinue this product.
40mg/0.4mL (NDCs 0781-3224-02 and 0781-3224-64) 07/02/2018 Sandoz Inc. has made a business decision to permanently discontinue this product.
60mg/0.6mL (NDCs 0781-3356-03 and 0781-3356-66) 07/02/2018 Sandoz Inc. has made a business decision to permanently discontinue this product.
80mg/0.8mL (NDCs 0781-3428-04 and 0781-3428-68) 07/02/2018 Sandoz Inc. has made a business decision to permanently discontinue this product.
100mg/mL (NDCs 0781-3500-05 and 0781-3500-69) 07/02/2018 Sandoz Inc. has made a business decision to permanently discontinue this product.
120mg/0.8mL (NDCs 0781-3612-04 and 0781-3612-68) 07/02/2018 Sandoz Inc. has made a business decision to permanently discontinue this product.
150mg/mL (NDCs 0781-3655-05 and 0781-3655-69) 07/02/2018 Sandoz Inc. has made a business decision to permanently discontinue this product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English